Literature DB >> 23549515

Impact of retransfusion of blood processed in cell-saver on coagulation versus cardiopulmonary bypass: a prospective observational study using thromboelastography.

Tomas Vymazal1, Martin Filaun, Michal Horacek.   

Abstract

AIMS: To compare an impact of retransfusion of blood processed in cell-saver (CS) with that of cardiopulmonary bypass (CPB) on blood coagulation in patients undergoing cardiac surgery.
METHODS: Prospective observational study using thromboelastography (TEG).
RESULTS: TEG samples from 170 patients were analyzed. Cardiopulmonary bypass was used in 100 patients while 70 patients were operated off-pump. In 20 off-pump patients collected blood was processed by cell-saver and returned. In all patients clot formation after heparin neutralization by protamine was unimpaired. However, there was a significant increase in fibrinolysis defined by the TEG parameter Lysis time 30 min after the maximum amplitude of the clot was reached (Ly30) in groups with CPB or CS but this increase still did not exceed the threshold for clinical fibrinolysis (Ly30 > 7.5%). In the group without CPB there was no significant impact on coagulation.
CONCLUSION: Surgery that avoids CPB and/or CS is the gentlest method for inducing blood coagulation.

Entities:  

Mesh:

Year:  2013        PMID: 23549515     DOI: 10.5507/bp.2013.012

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  2 in total

1.  Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.

Authors:  Sheliang Shen; Jun Zhang; Wenyuan Wang; Jiayin Zheng; Yihong Xie
Journal:  J Transl Med       Date:  2016-07-29       Impact factor: 5.531

2.  Direct thrombolysis of multiple thrombi in both right and left heart atrium in a patient on extracorporeal membrane oxygenation support following urgent double-lung transplantation: a case report.

Authors:  Lukas Pollert; Zuzana Prikrylova; Jan Berousek; Frantisek Mosna; Robert Lischke
Journal:  Ther Clin Risk Manag       Date:  2016-06-16       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.